In fact, several animal models of obesity and HFD have also demonstrated that certain HDAC inhibitors can effectively reduce adiposity, improve leptin sensitivity, increase energy expenditure, and improve insulin sensitivity and glucose homeostasis in obese animals. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.